PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Drop in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 36,518 shares, a drop of 16.1% from the November 30th total of 43,518 shares. Based on an average daily trading volume, of 974 shares, the days-to-cover ratio is currently 37.5 days. Based on an average daily trading volume, of 974 shares, the days-to-cover ratio is currently 37.5 days.

PureTech Health Stock Performance

PTCHF stock opened at $1.71 on Friday. PureTech Health has a 52-week low of $1.27 and a 52-week high of $1.90. The company’s 50 day simple moving average is $1.67 and its 200-day simple moving average is $1.69.

PureTech Health Company Profile

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.